Omeir R, Thomas R, Teferedegne B, Williams C, Foseh G, Macauley J, Brinster L, Beren J, Peden K, Breen M, Lewis A M
Laboratory of DNA Viruses, Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD, 20993, USA.
Department of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, 1060 William Moore Drive, Raleigh, NC, 27607, USA.
Chromosome Res. 2015 Dec;23(4):663-80. doi: 10.1007/s10577-015-9474-8. Epub 2015 May 10.
The molecular mechanisms underlying spontaneous neoplastic transformation in cultured mammalian cells remain poorly understood, confounding recognition of parallels with the biology of naturally occurring cancer. The broad use of tumorigenic canine cell lines as research tools, coupled with the accumulation of cytogenomic data from naturally occurring canine cancers, makes the domestic dog an ideal system in which to investigate these relationships. We developed a canine kidney cell line, CKB1-3T7, which allows prospective examination of the onset of spontaneous immortalization and tumorigenicity. We documented the accumulation of cytogenomic aberrations in CKB1-3T7 over 24 months in continuous culture. The majority of aberrations emerged in parallel with key phenotypic changes in cell morphology, growth kinetics, and tumor incidence and latency. Focal deletion of CDKN2A/B emerged first, preceding the onset and progression of tumorigenic potential, and progressed to a homozygous deletion across the cell population during extended culture. Interestingly, CKB1-3T7 demonstrated a tumorigenic phenotype in vivo prior to exhibiting loss of contact inhibition in vitro. We also performed the first genome-wide characterization of the canine tumorigenic cell line MDCK, which also exhibited CDKN2A/B deletion. MDCK and CKB1-3T7 cells shared several additional aberrations that we have reported previously as being highly recurrent in spontaneous canine cancers, many of which, as with CDKN2A/B deletion, are evolutionarily conserved in their human counterparts. The conservation of these molecular events across multiple species, in vitro and in vivo, despite their contrasting karyotypic architecture, is a powerful indicator of a common mechanism underlying emerging neoplastic activity. Through integrated cytogenomic and phenotypic characterization of serial passages of CKB1-3T7 from initiation to development of a tumorigenic phenotype, we present a robust and readily accessible model (to be made available through the American Type Culture Collection) of spontaneous neoplastic transformation that overcomes many of the limitations of earlier studies.
培养的哺乳动物细胞中自发肿瘤转化的分子机制仍未得到充分理解,这使得人们难以识别其与自然发生癌症生物学之间的相似之处。将致瘤性犬细胞系广泛用作研究工具,再加上来自自然发生的犬类癌症的细胞基因组数据的积累,使得家犬成为研究这些关系的理想系统。我们开发了一种犬肾细胞系CKB1-3T7,它可以对自发永生化和致瘤性的发生进行前瞻性研究。我们记录了CKB1-3T7在连续培养24个月期间细胞基因组畸变的积累情况。大多数畸变与细胞形态、生长动力学以及肿瘤发生率和潜伏期等关键表型变化同时出现。CDKN2A/B的局灶性缺失首先出现,先于致瘤潜能的发生和进展,并在长期培养过程中发展为整个细胞群体的纯合缺失。有趣的是,CKB1-3T7在体外表现出接触抑制丧失之前就在体内表现出致瘤表型。我们还对犬致瘤细胞系MDCK进行了首次全基因组表征,该细胞系也表现出CDKN2A/B缺失。MDCK和CKB1-3T7细胞共有其他几种畸变,我们之前报道这些畸变在自发犬类癌症中高度复发,其中许多畸变,与CDKN2A/B缺失一样,在其人类对应物中具有进化保守性。尽管不同物种的核型结构不同,但这些分子事件在体外和体内的多个物种中都具有保守性,这有力地表明了新出现的肿瘤活性背后存在共同机制。通过对CKB1-3T7从起始到致瘤表型发展的连续传代进行综合细胞基因组和表型表征,我们提出了一个强大且易于获取的自发肿瘤转化模型(将通过美国模式培养物集存库提供),该模型克服了早期研究的许多局限性。